Prosecution Insights
Last updated: November 04, 2026
Application No. 18/982,131

DEVICES AND METHODS FOR FACILITATING THE ADVANCEMENT OF TREATMENT DEVICES FOR NEUROVASCULAR PROCEDURES

Non-Final OA §102§103
Filed
Dec 16, 2024
Priority
Dec 22, 2023 — provisional 63/613,828
Examiner
OUYANG, BO
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Baylis Medical Technologies Inc.
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
2y 1m
Est. Remaining
69%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
251 granted / 413 resolved
-9.2% vs TC avg
Moderate +9% lift
Without
With
+8.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 12m
Avg Prosecution
35 currently pending
Career history
466
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
58.4%
+18.4% vs TC avg
§102
21.4%
-18.6% vs TC avg
§112
16.3%
-23.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 413 resolved cases

Office Action

§102 §103
DETAILED ACTION Applicant's preliminary amendments, filed 3/14/25, are fully acknowledged by the Examiner. Currently, claims 1-7, 9, 11-16, 18, 19, and 24-27 are pending with claims 8, 10, 17, 20-23 canceled, and claims 4-5, 7-8, 10, 14, 18, 20, 26-27, and 32 amended. The following is a complete response to the 3/14/25 communication. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 2, 8, 10, 12, 22-23, 26-27 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Koblish (US 2020/0107877). Regarding claim 1, Koblish teaches a probe for forming a lesion in a target tissue (1800), the probe comprising: an elongate member extending longitudinally between a proximal end and a distal end (shaft of catheter), wherein the elongate member has an active electrode proximate the distal end for delivering ablative energy to the target tissue (electrode 180 for delivering ablation energy as in par. [0445]), and an electrically insulated section proximal of the active electrode (insulated section), and wherein the active electrode has a cooled section that is coolable by receipt of a cooling fluid delivered through the elongate member (the active electrode with a cooled section through 1804 as in par. [0448]); and at least a first temperature sensor positioned external of the elongate member to measure a temperature in a heat affected zone of the target tissue (temperature sensor 1880), wherein the first temperature sensor is positioned proximally of the distal end and is spaced from the cooled section (1880 proximally of the distal end and is spaced from the cooled section 1850 that corresponds to 1830). Regarding claim 2, Koblish teaches wherein the elongate member comprises at least a first fluid delivery lumen for delivering the cooling fluid through the elongate member to the cooled section (cooling lumen 1804 as in par. [0448]). Regarding claim 8, Koblish teaches wherein the first temperature sensor is positioned proximally of the active electrode (1880 is proximal of 1830 as in Fig. 13, par. [0008]). Regarding claim 10, Koblish teaches wherein the first temperature sensor is positioned to measure the temperature in a proximal projection of a thermal ablation zone (par. [0450] sensor on outside of catheter to detect temperature adjacent tissue, and proximal as in Fig. 13). Regarding claim 12, Koblish teaches wherein the first temperature sensor is spaced at least proximally from the cooled section (1880 is proximal to the cooled section 1850 corresponding to 1830). Regarding claim 18, Koblish teaches further comprising at least one electrical conductor for electrically connecting the first temperature sensor to a temperature control system (par. [0514]), wherein the electrical conductor extends through a lumen of the elongate member (Fig. 5). Regarding claim 22, Koblish teaches a system for forming a lesion in a target tissue, comprising: a probe comprising an elongate member and a first temperature sensor (1800 with catheter and sensor 1880), wherein the elongate member extends longitudinally between a proximal end and a distal end (catheter with a proximal and distal end), wherein the elongate member has an active electrode proximate the distal end for delivering ablative energy to the target tissue (1830 at a distal end of the catheter as in at least Fig. 13), and an electrically insulated section proximal of the active electrode (temperature sensors are electrically insulated as in at least pars. [0174], [0480]), wherein the active electrode comprises a cooled section that is coolable by receipt of a cooling fluid delivered through the elongate member (1830 with a cooled section cooled by 1820), wherein the first temperature sensor is positioned external of the elongate member to measure a temperature in a heat affected zone of the target tissue (1880 external of the catheter as in Fig. 13), and wherein the first temperature sensor is positioned proximally of the distal end and is spaced from the cooled section (1880 proximal of 1830 as in at least Fig. 13); a return electrode spaced from the active electrode (ground pad electrode as in at least par. [0014]); a radiofrequency generator electrically connected to the active electrode for delivering the ablative energy to the active electrode and electrically connected to the return electrode for returning a return current to the radiofrequency generator (RF generator as in par. [0282]); and a cooling fluid circulation system for delivering the cooling fluid to the probe (par. [0448] irrigation system with passage 1804). Regarding claim 23, Koblish teaches a method for forming a lesion in a target tissue, comprising: positioning an active electrode of a probe at the target tissue (electrode 1830 at target);delivering ablative energy from the active electrode to form the lesion in the target tissue (1830 delivers ablation energy), while delivering a cooling fluid to a cooled section of the active electrode (cooling fluid delivered from 1804 to 1820); and using a first temperature sensor of the probe to monitor a temperature in a heat affected zone of the target tissue at a position proximal of a distal end of the probe and spaced from the cooled section (1880 to sense temperature in target tissue proximal the probe distal end and spaced from the cooled section). Regarding claim 26, Koblish teaches wherein using the first temperature sensor comprises monitoring the temperature proximally of the active electrode (1880 senses temperature proximal of 1830). Regarding claim 27, Koblish teaches wherein the lesion has a proximal projection, and the first temperature sensor monitors the temperature in the proximal projection (1880 senses temperature in the lesion created by the ablation procedure). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 4-7, 25 and 28 is/are rejected under 35 U.S.C. 103 as being unpatentable over Koblish in view of Cao (US 2018/0028262). Regarding claim 4, Koblish is not explicit wherein the elongate member is configured to restrict the cooling fluid to the cooled section on delivery of the cooling fluid.However, Cao teaches an elongate member that is able to restrict cooling fluid to limit delivery of cooling fluid (par. [0044] using 415 to restrict cooling fluid delivery). It would have been obvious to one of ordinary skill in the art to modify Koblish with the plunger mechanism of Cao, to regulate the cooling fluid delivered by the device. Regarding claim 5, Koblish teaches further comprising a barrier within the elongate member for restricting the cooling fluid to the cooled section on delivery of the cooling fluid, wherein the barrier is positioned distally of a proximal boundary of the active electrode, to further provide the active electrode with a non-cooled section.However, Cao teaches an elongate member that is able to restrict cooling fluid to limit delivery of cooling fluid (par. [0044]), with a barrier to restrict the cooling fluid (barrier 415).It would have been obvious to one of ordinary skill in the art to modify Koblish with the plunger mechanism of Cao, to regulate the cooling fluid delivered by the device. Regarding claim 6, Koblish teaches wherein the first temperature sensor is secured to the active electrode in the non-cooled section (1880 secured to electrode 1830). Regarding claim 7, Koblish is not explicit regarding further comprising a barrier within the elongate member for restricting the cooling fluid to the cooled section on delivery of the cooling fluid, wherein the barrier is positioned at a proximal boundary of the active electrode so that the cooled section makes up an entirety of the active electrode.However, Cao teaches an elongate member that is able to restrict cooling fluid to limit delivery of cooling fluid (par. [0044]), with a barrier to restrict the cooling fluid positioned at a proximal boundary of the active electrode so that the cooled section makes up an entirety of the active electrode (barrier 415 blocks fluid to selectively cool).It would have been obvious to one of ordinary skill in the art to modify Koblish with the plunger mechanism of Cao, to regulate the cooling fluid delivered by the device. Regarding claim 25, Koblish is silent wherein delivering the cooling fluid to the cooled section of the active electrode comprises, on delivery of the cooling fluid, restricting the cooling fluid to the cooled section.However, Cao teaches an elongate member that is able to restrict cooling fluid to limit delivery of cooling fluid (par. [0044]), with a barrier to restrict the cooling fluid (barrier 415).It would have been obvious to one of ordinary skill in the art to modify Koblish with the plunger mechanism of Cao, to regulate the cooling fluid delivered by the device. Regarding claim 28, wherein restricting the cooling fluid to the cooled section comprising using a barrier positioned at a proximal boundary of the active electrode to restrict the cooling fluid to the active electrode.However, Cao teaches an elongate member that is able to restrict cooling fluid to limit delivery of cooling fluid (par. [0044]), with a barrier to restrict the cooling fluid (barrier 415).It would have been obvious to one of ordinary skill in the art to modify Koblish with the plunger mechanism of Cao, to regulate the cooling fluid delivered by the device. Claim(s) 14 and 15 is/are rejected under 35 U.S.C. 103 as being unpatentable over Koblish in view of Gelfand (US 10,219,855). Regarding claim 14, Koblish is not explicit wherein the elongate member comprises a metallic hypotube, wherein the metallic hypotube comprises a first section that is electrically exposed to form the active electrode, and a second section on which an electrically insulative material is received to form the electrically insulated section.However, Gelfand teaches the RF electrode of a similar probe device made of a metal hypotube with an exposed electrical section for an electrode and an insulated section (col. 33 lines 25-45).It would have been obvious to one of ordinary skill in the art to modify Koblish with the hypotube structure of Gelfand, as a structure that can better define where the insulation is for the temperature sensor of Koblish. Regarding claim 15, Koblish teaches further comprising at least one electrical conductor for electrically connecting the first temperature sensor to a temperature control system (par. [0549] temperature control from module 40, connecting to temperature sensors via conductors as in par. [0514]), but is not explicit wherein the electrical conductor is positioned between the second section of the metallic hypotube and the electrically insulative material.However, Gelfand teaches the insulative material proximal the electrode as in Fig. 14 and col. 33 lines 25-45.It would have been obvious to one of ordinary skill in the art to modify Koblish with the hypotube structure of Gelfand, as a structure that can better define where the insulation is for the temperature sensor of Koblish. Claim(s) 20 and 32 is/are rejected under 35 U.S.C. 103 as being unpatentable over Koblish in view of Govari (US 2021/0196371). Regarding claim 20, Koblish is not explicit wherein the first temperature sensor is further configured to deliver ablative energy to the target tissue.However, Govari teaches using an electrode for both temperature sensing and RF ablation (par. [0026]).It would have been obvious to one of ordinary skill in the art to modify Koblish with the temperature sensor of Govari to also deliver ablative energy. This would allow for multiple functions of the temperature sensor. Regarding claim 32, Koblish is not explicit regarding further comprising delivering the ablative energy to the target tissue from the first temperature sensor.However, Govari teaches using an electrode for both temperature sensing and RF ablation (par. [0026]).It would have been obvious to one of ordinary skill in the art to modify Koblish with the temperature sensor of Govari to also deliver ablative energy. This would allow for multiple functions of the temperature sensor. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BO OUYANG whose telephone number is (571)272-8831. The examiner can normally be reached M-F 8-5 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joanne Rodden can be reached at 303-297-4276. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BO OUYANG/Examiner, Art Unit 3794 /MICHAEL F PEFFLEY/Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Dec 16, 2024
Application Filed
Sep 16, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778666
INSERT GUIDE MEMBERS FOR SURGICAL INSTRUMENTS, AND RELATED DEVICES, SYSTEMS, AND METHODS
2y 4m to grant Granted Nov 03, 2026
Patent 12773257
KNIFE HOUSING FOR SURGICAL TOOL END EFFECTORS
3y 8m to grant Granted Oct 27, 2026
Patent 12773261
ROTATABLE SNARES AND RELATED METHODS
2y 3m to grant Granted Oct 27, 2026
Patent 12765945
MEDICAL DEVICE WITH AN IRRIGATION MANIFOLD
3y 0m to grant Granted Oct 20, 2026
Patent 12758300
PRESSURE RELIEF VENT FOR SURGICAL SEALING DEVICES
4y 0m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
69%
With Interview (+8.6%)
3y 12m (~2y 1m remaining)
Median Time to Grant
Low
PTA Risk
Based on 413 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month